| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $7.40B | $6.94B | $6.60B | $6.15B | $5.55B |
| Cost of Revenue | $4.73B | $4.46B | $4.21B | $4.01B | $3.63B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $236.10M | $236.60M | $220.80M | $198.80M | $194.20M |
| SG&A | $757.12M | $696.90M | $677.01M | $644.58M | $603.94M |
| Operating Income | $1.91B | $1.78B | $1.71B | $1.50B | $1.31B |
| Interest Expense | – | – | $81.80M | $83.19M | $80.38M |
| Tax Expense | $318.20M | $285.42M | $293.22M | $269.15M | $233.12M |
| Net Income | $1.48B | $1.38B | $1.31B | $1.16B | $990.05M |
| EPS (basic) | 6.4200 | 5.9500 | 5.7000 | 5.0400 | 4.2900 |
| EPS (diluted) | 6.4000 | 5.9300 | 5.6700 | 5.0100 | 4.2500 |
| Shares (diluted) | $231.26M | $232.17M | $231.51M | $231.54M | $232.81M |